Atlas Trials

Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer

Clinical trial NCT00466089 · UNKNOWN

Trial details

NCT number
NCT00466089
Sponsor
Hospital of Navarra
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2006-03-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.